| Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity A Toso, A Revandkar, D Di Mitri, I Guccini, M Proietti, M Sarti, S Pinton, ... Cell reports 9 (1), 75-89, 2014 | 402 | 2014 |
| Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells BT Kawasaki, T Mistree, EM Hurt, M Kalathur, WL Farrar Biochemical and biophysical research communications 364 (4), 778-782, 2007 | 144 | 2007 |
| Effects of the sesquiterpene lactone parthenolide on prostate tumor‐initiating cells: An integrated molecular profiling approach BT Kawasaki, EM Hurt, M Kalathur, MA Duhagon, JA Milner, YS Kim, ... The Prostate 69 (8), 827-837, 2009 | 118 | 2009 |
| CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo BT Spike, JA Kelber, E Booker, M Kalathur, R Rodewald, J Lipianskaya, ... Stem cell reports 2 (4), 427-439, 2014 | 76 | 2014 |
| A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours Nature Communications 6, 2015 | 42 | 2015 |
| Stress response pathways in cancer GT Wondrak Springer, 2015 | 9* | 2015 |
| Pro-senescence therapy for cancer: Time for the clinic M Kalathur, D Di Mitri, A Alimonti Stress Response Pathways in Cancer: From Molecular Targets to Novel …, 2015 | 3 | 2015 |
| Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells M Colucci, S Zumerle, S Bressan, F Gianfanti, M Troiani, A Valdata, ... Cancer Cell, 2024 | | 2024 |
| Protein kinase CK2 as a novel target for pro-senescence therapy in Pten null tumors M Kalathur Université de Lausanne, Faculté de biologie et médecine, 2016 | | 2016 |
| Cripto/GRP78 signaling promotes the stem cell phenotype in normal and neoplastic mammary epithelial cells BT Spike, JA Kelber, E Booker, M Kalathur, R Rodewald, J Lipianskaya, ... Cancer Research 74 (19_Supplement), 3035-3035, 2014 | | 2014 |
| A chemogenomic screening platform for identification of protein kinase CK2 as a novel target for prosenescence therapy in PTEN-null tumors. M Kalathur, A Toso, J Chen, A Revandkar, C Danzer-Baltzer, I Frew, ... Journal of Clinical Oncology 32 (15_suppl), 11116-11116, 2014 | | 2014 |
| Soluble ALK4 extracellular domain antagonizes the cancer/stem cell phenotype caused by Nodal and Cripto signaling in mammary epithelia BT Spike, JA Kelber, M Kalathur, E Booker, J Lipianskaya, R Klemke, ... Cancer Research 72 (8_Supplement), 3493-3493, 2012 | | 2012 |
| Cancer Stem Cells in Lung and Pleural Malignancies M Kalathur, MD Paolo Macchiarini Current Medical Literature 4 (3), 69, 2011 | | 2011 |
| Julia Lipianskaya, Justin La, Marielle He, 2 Tracy Wright, 3 Richard Klemke, 3 Geoffrey M. Wahl, and Peter C. Gray 2 BT Spike, JA Kelber, E Booker, M Kalathur, R Rodewald | | |
